|
0
|
6
|
4lkmB |
Crystal structure of plk1 polo-box domain in complex with pl-74 |
|
75
|
231
|
4lkmA |
Crystal structure of plk1 polo-box domain in complex with pl-74 |
|
84
|
272
|
6oipA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 34 |
|
81
|
273
|
6oioA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 60 |
|
82
|
272
|
6oinA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor ctx-124143 |
|
84
|
272
|
6oirA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 62 |
|
84
|
272
|
6oiqA |
Crystal structure of myst acetyltransferase domain in complex with inhibitor 63 |
|
0
|
5
|
4jx7B |
Crystal structure of pim1 kinase in complex with inhibitor 2-[(trans-4-aminocyclohexyl)amino]-4-{[3-(trifluoromethyl)phenyl]amino}pyrido[4,3-d]pyrimidin-5(6h)-one |
|
0
|
6
|
4e67B |
The structure of the polo-box domain (pbd) of polo-like kinase 1 (plk1) in complex with hydrocinnamoyl-derivatized plhspta peptide |
|
0
|
5
|
3q4jL |
Structure of a small peptide ligand bound to e.coli dna sliding clamp |
|
0
|
5
|
4habD |
Crystal structure of plk1 polo-box domain in complex with pl-49 |
|
0
|
6
|
4lklB |
Crystal structure of plk1 polo-box domain in complex with pl-55 |
|
0
|
7
|
4e9cB |
The structure of the polo-box domain (pbd) of polo-like kinase 1 (plk1) in complex with ldpplhspta phosphopeptide |
|
0
|
8
|
4e9dE |
The structure of the polo-box domain (pbd) of polo-like kinase 1 (plk1) in complex with 3-(1-benzothiophen-2-yl)propanoyl-derivatized dpplhspta peptide |
|
145
|
551
|
5hroA |
Structure of hiv-1 reverse transcriptase in complex with a dna aptamer and an alpha-carboxy nucleoside phosphonate inhibitor (alpha-cnp) |
|
115
|
378
|
6mvdA |
Crystal structure of lecithin:cholesterol acyltransferase (lcat) in complex with isopropyl dodec-11-enylfluorophosphonate (idfp) and a small molecule activator |
|
277
|
716
|
6ma2A |
Crystal structure of human o-glcnac transferase bound to a peptide from hcf-1 pro-repeat 2 (11-26) and inhibitor ent-1a |
|
275
|
716
|
6ma5A |
Crystal structure of human o-glcnac transferase bound to a peptide from hcf-1 pro-repeat 2 (11-26) and inhibitor 1a |
|
269
|
716
|
6ma1A |
Crystal structure of human o-glcnac transferase bound to a peptide from hcf-1 pro-repeat 2 (11-26) and inhibitor 4a |
|
278
|
716
|
6ma3A |
Crystal structure of human o-glcnac transferase bound to a peptide from hcf-1 pro-repeat 2 (11-26) and inhibitor 2a |
|
0
|
14
|
6ma5B |
Crystal structure of human o-glcnac transferase bound to a peptide from hcf-1 pro-repeat 2 (11-26) and inhibitor 1a |
|
0
|
14
|
6ma4B |
Crystal structure of human o-glcnac transferase bound to a peptide from hcf-1 pro-repeat 2 (11-26) and inhibitor 3a |
|
0
|
13
|
6ma3B |
Crystal structure of human o-glcnac transferase bound to a peptide from hcf-1 pro-repeat 2 (11-26) and inhibitor 2a |
|
86
|
287
|
6dudA |
Jak3 with cyanamide cp12 |
|
2
|
18
|
6e9lB |
Crystal structure of protein kinase a in complex with the pki peptide and a pyridinylbenzamide based inhibitor |
|
109
|
389
|
6ed6A |
Crystal structure of rock2 with a pyridinylbenzamide based inhibitor |
|
112
|
396
|
6e9wA |
Crystal structure of rock1 with a pyridinylbenzamide based inhibitor |
|
101
|
334
|
6e9lA |
Crystal structure of protein kinase a in complex with the pki peptide and a pyridinylbenzamide based inhibitor |
|
91
|
271
|
6di1A |
Crystal structure of btk in complex with covalent fragment ligand |
|
92
|
271
|
6di0A |
Crystal structure of btk in complex with fragment ligand |
|
91
|
309
|
6brjA |
Ddr1 bound to vx-680 |
|
92
|
309
|
6bsdA |
Ddr1 bound to dasatinib |
|
201
|
547
|
5qj1A |
Crystal structure of the hepatitis c virus genotype 2a strain jfh1 l30s ns5b rna-dependent rna polymerase in complex with 6-(ethylamino)-2-(4-fluorophenyl)-5-(3-{[1-(5-fluoropyrimidin-2-yl)cyclopropyl]carbamoyl}-4-methoxyphenyl)-n-methyl-1-benzofuran-3-carboxamide |
|
105
|
321
|
6npnA |
Crystal structure of the human vaccinia-related kinase bound to a n,n-dipropynyl-dihydropteridine-3-hydroxyindazole inhibitor |
|
204
|
569
|
5qj0A |
Crystal structure of the hepatitis c virus genotype 2a strain jfh1 ns5b rna-dependent rna polymerase in complex with 6-[ethyl(methylsulfonyl)amino]-2-(4-fluorophenyl)-n-methyl-5-(3-{[1-(pyrimidin-2-yl)cyclopropyl]carbamoyl}phenyl)-1-benzofuran-3-carboxamide |
|
72
|
198
|
5yx1A |
Crystal structure of hematopoietic prostaglandin d synthase in complex with u004 |
|
100
|
302
|
5qinA |
Tgf-beta receptor type 2 kinase domain in complex with n- {4-[3-(6-methoxypyridin-3-yl)-1h-pyrrolo[3,2-b]pyridin-2- yl]pyridin-2-yl}acetamide |
|
99
|
303
|
5qilA |
Tgf-beta receptor type 1 kinase domain (t204d) in complex with n-{4-[3-(6-methoxypyridin-3-yl)-1h-pyrrolo[3,2-b]pyridin-2-yl]pyridin-2-yl}acetamide |
|
98
|
304
|
5qimA |
Tgf-beta receptor type 1 kinase domain (t204d) in complex with n-{4-[3-(5-methoxypyridin-2-yl)-1h-pyrrolo[3,2-b] pyridin-2-yl]pyridin-2-yl}acetamide |
|
101
|
303
|
5qikA |
Tgf-beta receptor type 1 kinase domain (t204d) in complex with n-{4-[3-(6-fluoropyridin-3-yl)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide |
|
109
|
362
|
6naoA |
Discovery of a high affinity inhibitor of cgas |
|
79
|
268
|
6nfiA |
Btk in complex with inhibitor n-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazol-6-yl)methanesulfonamide |
|
113
|
361
|
6nfgA |
Cyclic gmp-amp synthase in complex with compound 16 inhibitor: 7-hydroxy-n-methyl-5-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
90
|
271
|
6nfhA |
Btk in complex with inhibitor 8-(2,3-dihydro-1h-inden-5-yl)-2-({4-[(2s)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione |
|
83
|
302
|
6mzwA |
Tas-120 covalent complex with fgfr1 |
|
85
|
302
|
6mzqA |
Tas-120 in reversible binding mode with fgfr1 |
|
100
|
296
|
6n8gA |
Irak4 bound to benzoxazole compound |
|
86
|
244
|
6mhdA |
Glutathione s-transferase omega 1 bound to covalent inhibitor 44 |
|
77
|
236
|
6mhbA |
Glutathione s-transferase omega 1 bound to covalent inhibitor 18 |
|
78
|
242
|
6m8aA |
Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with luteolin |
